Clinical trial

Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.

NCT00393471

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2000-10-01

PhasePHASE3

Study timeline

Study start (unknown)2000-10-01Date precision: month

Registry last updated2023-12-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Active Rheumatoid Arthritisunresolved

Interventions

EtanerceptDRUG · verified · RxNorm: etanercept

Sponsors & collaborators

Wyeth is now a wholly owned subsidiary of Pfizerlead sponsor

Mapped research locations

MadridSpain3 ParisFrance3 MilanItaly2 LisbonPortugal2 BarcelonaSpain1 LondonUnited Kingdom1 BerlinGermany1 WarsawPoland1 PragueCzechia1 ToulouseFrance1 MontpellierFrance1 BrusselsBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00393471 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.